FGH Biotech, Inc. — Form D

FGH Biotech, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2017-09-06. The offering totals $4.0M. Industry: Pharmaceuticals.

Offering

• Filed: 2017-09-06
• Form: D
• Accession: 0001657572-17-000001
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $4.0M
• Remaining: $4.0M
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-294133

Issuer

• Name: FGH Biotech, Inc.
• CIK: 0001657572
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2011
• Address: 414 THAMER CIRCLE, HOUSTON, TX, 77024
• Phone: 7134654028

Officers, directors & promoters (6)

Other filings by this issuer (2)

More

• CIK 1657572 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search